Item added to your cart
Scalp solution that stimulates hair growth in men with androgenic alopecia.
Contains 60 ml.
It is a medicine formulated with minoxidil in solution that is used on the skin of the scalp to stimulate hair growth in men with androgenic alopecia.
It is formulated for use in adult men over the age of 18 and under the age of 65.
It is not indicated for women or pregnant women, except in case of medical prescription.
The recommended dosage is 2 ml per day, divided into two doses of 1 ml (equivalent to 6 sprays), one in the morning and one in the evening.
Wash hands before and after use to prevent hair from appearing on other parts of the body.
Do not use Minoxidil Viñas:
In children under 18 years of age and over 65 years of age.
In case of allergy to minoxidil or to any of the components present in this medicine.
If you suffer from any injury to the skin of the scalp.
If you suffer from heart problems or high blood pressure, unless accompanied by medical supervision.
In women, due to the possibility of hypertrichosis in other areas of the body.
Minoxidil Viñas may cause side effects, as with all medicines. Specifically, the following have been observed:
Frequent: pruritus (itching), local skin irritation, contact dermatitis (redness), skin dryness and peeling (flaking of the skin).
Rare: headache and paraesthesia (numbness in arms or legs). Tachycardia, palpitations and hypotension (low blood pressure). Rash erythematosus (generalised redness), eczema, alopecia and hypertrichosis (hair growth on the skin).
Rare: pustular rash (generalised pustules) and acne.
Very rare: visual disturbances and eye irritation.
Each ml of solution contains 50 mg of minoxidil. The other excipients are: propylene glycol, ethanol 96% and purified water.
Apply with the fingertips from the inside to the outside of the area to be treated, taking into account that the treated area should not be exposed to the sun without adequate sun protection.
This product is available in various presentations depending on the needs of each patient.
For more information, please consult our team of pharmaceutical experts.
